HomeLombard Medical

Lombard Medical

Lombard Medical Announces First Patient Enrolled and Treated in the ALTITUDE Registry for the Altura® Stent Graft System

“I am encouraged by our positive early clinical experience with Altura. The simplicity of planning, accuracy of deployment and repositionability could lead to it becoming a workhorse device in the future. The ALTITUDE registry will provide a...

Lombard Medical’s Endovascular Product Portfolio Presented at Scientific Sessions of the 39th Annual Charing Cross International Symposium

  Portfolio of endovascular stent graft systems, Altura® and Aorfix™ announced at London, United Kingdom, conference Lombard Medical, Inc. (NASDAQ: EVAR), a developer, manufacturer and marketer of endovascular aortic aneurysm repair products, today announced that its portfolio of endovascular...

Lombard Medical and MicroPort Scientific Corporation Finalize Strategic Partnership Agreements

Aorfix™, is the only stent graft to hold global approvals to treat AAA with aortic neck angles up to 90 degrees, and Altura®, an innovative stent graft and ultra-low profile delivery system that offers an easy to use and predictable treatment option for standard AAA anatomy.

Lombard Medical Announces Successful Completion of First 15 Cases in Japan for IntelliFlex LP Delivery System for the Aorfix™ Endovascular Stent Graft

Lombard Medical, Inc. a medical device company focused on endovascular aneurysm repair (EVAR) of abdominal aortic aneurysms (AAAs), today announced that physicians in Japan have successfully treated the first 15 patients using its innovative new IntelliFlex™ LP...